Butirosin B
ID: ALA605012
PubChem CID: 46873952
Max Phase: Preclinical
Molecular Formula: C21H41N5O12
Molecular Weight: 555.58
Molecule Type: Small molecule
Associated Items:
This compound is not in our inventory system
ID: ALA605012
PubChem CID: 46873952
Max Phase: Preclinical
Molecular Formula: C21H41N5O12
Molecular Weight: 555.58
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NCCC(O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2N)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)[C@H]1O
Standard InChI: InChI=1S/C21H41N5O12/c22-2-1-8(28)19(34)26-7-3-6(24)17(37-20-11(25)15(32)13(30)9(4-23)35-20)18(12(7)29)38-21-16(33)14(31)10(5-27)36-21/h6-18,20-21,27-33H,1-5,22-25H2,(H,26,34)/t6-,7+,8?,9+,10+,11+,12-,13+,14+,15+,16+,17+,18-,20+,21-/m0/s1
Standard InChI Key: XEQLFNPSYWZPOW-QDHZCZDFSA-N
Molfile:
RDKit 2D 38 40 0 0 0 0 0 0 0 0999 V2000 3.6375 -2.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.9125 -2.3583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1750 -4.7958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3875 -2.9958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1500 -2.3083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7875 -5.5458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4250 -2.9958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1000 -3.7167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.3875 -1.6958 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.1500 -4.2167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.6125 -2.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4750 -3.0167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.1125 -2.3083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.5250 -5.5458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0625 -2.3583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4250 -1.6958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.1375 -4.7958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.1125 -1.6458 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.7625 -1.2792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.6375 -1.6458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.6125 -1.6458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.7625 -0.5542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 7.6750 -0.1042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 6.4250 -1.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.2125 -6.2458 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.0875 -6.2542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 7.0500 -1.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.4250 -2.3792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 7.0500 -0.4958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8875 -2.3659 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.9792 -3.7057 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.0595 -3.7355 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.6537 -4.5622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.2517 -5.1306 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.7396 -3.7419 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.0527 -0.9596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7710 -0.9139 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.2652 -0.9096 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 10 3 1 0 11 1 1 0 5 12 1 6 13 11 1 0 14 6 1 0 15 16 1 0 16 9 1 0 17 10 1 0 13 18 1 1 19 18 1 0 20 5 1 0 21 13 1 0 22 19 2 0 23 29 1 0 24 19 1 0 6 25 1 6 14 26 1 6 27 24 1 0 28 24 1 0 29 27 1 0 20 21 1 0 14 17 1 0 7 15 1 0 15 30 1 6 2 12 1 6 11 31 1 6 3 8 1 1 7 32 1 1 4 2 1 0 17 33 1 1 5 1 1 0 33 34 1 0 6 3 1 0 4 35 1 6 7 4 1 0 16 36 1 1 1 8 1 6 36 37 1 0 9 2 1 0 20 38 1 1 M END
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 555.58 | Molecular Weight (Monoisotopic): 555.2752 | AlogP: -7.79 | #Rotatable Bonds: 10 |
Polar Surface Area: 311.71 | Molecular Species: BASE | HBA: 16 | HBD: 12 |
#RO5 Violations: 3 | HBA (Lipinski): 17 | HBD (Lipinski): 16 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.08 | CX Basic pKa: 9.61 | CX LogP: -7.95 | CX LogD: -13.85 |
Aromatic Rings: ┄ | Heavy Atoms: 38 | QED Weighted: 0.12 | Np Likeness Score: 1.54 |
1. Cashman DJ, Rife JP, Kellogg GE.. (2001) Which aminoglycoside ring is most important for binding? A hydropathic analysis of gentamicin, paromomycin, and analogues., 11 (2): [PMID:11206440] [10.1016/s0960-894x(00)00615-6] |
Source(1):